| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51 |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 51 |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 317 | 406 | 496 | 487 | | Selling General and Administrative | 316 | 500 | 593 | 433 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (583) | (906) | (1,089) | (920) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (42) | 27 | (24) | 5 | | Earnings Before Interest And Taxes | (625) | (880) | (1,113) | (915) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (625) | (880) | (1,113) | (915) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (625) | (880) | (1,113) | (915) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (625) | (880) | (1,113) | (915) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($625) | ($880) | ($1,113) | ($915) |
|
0.51% Nasdaq 
0.019 (3.39%) 
Income Statement
